Annual Drug Patent Expirations for TEMODAR
Temodar is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has thirty-three patent family members in twenty-three countries.
The generic ingredient in TEMODAR is temozolomide. One supplier is listed for this compound. Additional details are available on the temozolomide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
